U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H19N3.H2O4S
Molecular Weight 363.431
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ANTAZOLINE SULFATE

SMILES

OS(O)(=O)=O.C(N(CC1=CC=CC=C1)C2=CC=CC=C2)C3=NCCN3

InChI

InChIKey=UWOSJBSLQYMGDL-UHFFFAOYSA-N
InChI=1S/C17H19N3.H2O4S/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16;1-5(2,3)4/h1-10H,11-14H2,(H,18,19);(H2,1,2,3,4)

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/mesh/68000865

Antazoline is an antagonist of histamine H1 receptors. It selectively bind to but does not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. Antazoline in combination with naphazoline (VASOCON-A®) is indicated to relieve the symptoms of allergic conjunctivitis.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
38.4 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
VASOCON-A

Approved Use

Temporary relief of ocular redness and itching.

Launch Date

6.414336E11
PubMed

PubMed

TitleDatePubMed
Interactions of ligands at angiotensin II-receptors and imidazoline receptors.
2001 Feb
Pharmacometric analysis of alpha1-adrenoceptor function in rat tail artery pretreated with lipopolysaccharides.
2001 Nov-Dec
Inhibition of voltage-gated Ca2+ channels by antazoline.
2002 Oct 7
Conjunctival allergen challenge: models in the investigation of ocular allergy.
2003 Jul
Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats.
2003 Nov
The effects of imidazoline agents on the aggregation of human platelets.
2004 Feb
A rapid derivative spectrophotometric method for simultaneous determination of naphazoline and antazoline in eye drops.
2006 Jan
Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test.
2007 Jun 22
Demand for food and cocaine in Fischer and Lewis rats.
2009 Feb
Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice.
2010 May
Simultaneous determination of antazoline and naphazoline by the net analyte signal standard addition method and spectrophotometric technique.
2010 Nov-Dec
Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study.
2010 Sep-Oct
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
2011 Jul 14
Patents

Sample Use Guides

In Vivo Use Guide
1-2 drops up to 4 times daily.
Route of Administration: Other
In Vitro Use Guide
The antihistaminic agent, antazoline, was tested for its ability to compete for [3H]pyrilamine, [3H]tiotidine and [3H]N-methyl histamine binding to rodent brain H1, H2 and H3 histamine receptors, respectively. Antazoline exhibited the highest affinity for H1-receptors (dissociation constant, Ki = 38.4 +/- 4.4 nM), and was considerably weaker at H2- (K1 = 44,433 +/- 1,763 nM) and H3-receptors (Ki = 42,400 +/- 7,527 nM).
Name Type Language
ANTAZOLINE SULFATE
MART.   WHO-DD  
Common Name English
1H-IMIDAZOLE-2-METHANAMINE, 4,5-DIHYDRO-N-PHENYL-N-(PHENYLMETHYL)-, SULFATE (1:1)
Systematic Name English
ANTAZOLINE SULFATE [MART.]
Common Name English
ANTAZOLINE SULPHATE
Common Name English
Antazoline sulfate [WHO-DD]
Common Name English
2-IMIDAZOLINE, 2-((N-BENZYLANILINO)METHYL)-, SULFATE (1:1)
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29578
Created by admin on Fri Dec 15 17:15:01 UTC 2023 , Edited by admin on Fri Dec 15 17:15:01 UTC 2023
Code System Code Type Description
SMS_ID
100000092149
Created by admin on Fri Dec 15 17:15:01 UTC 2023 , Edited by admin on Fri Dec 15 17:15:01 UTC 2023
PRIMARY
DRUG BANK
DBSALT000910
Created by admin on Fri Dec 15 17:15:01 UTC 2023 , Edited by admin on Fri Dec 15 17:15:01 UTC 2023
PRIMARY
CAS
24359-81-7
Created by admin on Fri Dec 15 17:15:01 UTC 2023 , Edited by admin on Fri Dec 15 17:15:01 UTC 2023
PRIMARY
EVMPD
SUB00542MIG
Created by admin on Fri Dec 15 17:15:01 UTC 2023 , Edited by admin on Fri Dec 15 17:15:01 UTC 2023
PRIMARY
EPA CompTox
DTXSID30179096
Created by admin on Fri Dec 15 17:15:01 UTC 2023 , Edited by admin on Fri Dec 15 17:15:01 UTC 2023
PRIMARY
FDA UNII
6T74I07212
Created by admin on Fri Dec 15 17:15:01 UTC 2023 , Edited by admin on Fri Dec 15 17:15:01 UTC 2023
PRIMARY
PUBCHEM
3084423
Created by admin on Fri Dec 15 17:15:01 UTC 2023 , Edited by admin on Fri Dec 15 17:15:01 UTC 2023
PRIMARY
NCI_THESAURUS
C95310
Created by admin on Fri Dec 15 17:15:01 UTC 2023 , Edited by admin on Fri Dec 15 17:15:01 UTC 2023
PRIMARY